转基因 、基因编辑育种是生物育种的重要方面，也是迄今为止全球发展速度最快、应用范围最广、产业影响最大的现代生物育种技术。 今年是全球生物技术投入实际应用的第43年，也是生物技术作物商业化的第29年。截至2024年12月，已有30多个国家批准了转基因作物的种植。

Fintel reports that on December 16, 2024, JP Morgan downgraded their outlook for Editas Medicine (NasdaqGS:EDIT) from Neutral ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Fintel reports that on December 13, 2024, Chardan Capital downgraded their outlook for Editas Medicine (NasdaqGS:EDIT) from ...

2024年10月14日，《植物生物技术杂志（Plant Biotechnology Journal）》在线发表西南大学研究成果。研究人员通过比较CRISPR-Cas12a 和CRISPR-Cas9编辑系统敲除水稻非编码基因OsMIR390的效果，证实了Cas12a能够更有效敲除MicroRNA（miRNA）并产生可靠的功能缺失突变体。研究人员 ...

近日，上海交通大学生物医学工程学院宋萍团队在Journal of the American Chemical Society期刊上发表题为“Random Sanitization in DNA information storage using CRISPR-Cas12a”的最新研究。该研究开发了一种智能核酸探针杂交精准调控与CRISPR-Cas12a反式切割活性的选择性永久擦除方法 ...

Editas Medicine ( (EDIT) ) just unveiled an announcement.

In this study, we developed a rapid, sensitive, and visual detection method for MRV and ISKNV using the recombinase polymerase amplification (RPA)−CRISPR/Cas12a system. This method can detect as low ...

This cover highlights the article ZBTB48 is a priming factor regulating B-cell-specific CIITA expression by Grishma Rane, Dennis Kappei and colleagues. The study identifies how ZBTB48, represented as ...

However, while CRISPR sensing seems a promising alternative to established DNA detection techniques, it is not sensitive to epigenetic changes like hypermethylation. In this presentation, we showcase ...

School of Biomedical Engineering, The International Peace Maternity and Child Health Hospital, Zhangjiang Institute for Advanced Study and National Center for Translational Medicine, Shanghai Jiao ...